TBTimothy G. Brandon

Timothy G. Brandon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timothy G. Brandon has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HLA ‐B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study

    by Dimitrios V. Bikas, Timothy G. Brandon, Brittney N. Newby, Pamela F. Weiss

    Objective: This study aimed to investigate for possible association between HLA‐B genotype and disease phenotype in children with juvenile spondyloarthritis (JSpA). Methods: This was a cross‐sectional retrospective study of children evaluated at a large tertiary care rheumatology clinic. Inclusion criteria were (1) fulfillment of criteria for juvenile idiopathic arthritis (JIA) subtypes: enthesitis‐related arthritis (ERA), psoriatic arthritis (PsA), or undifferentiated JIA (ERA criteria plus a first‐degree relative with psoriasis); or (2) a diagnosis of inflammatory bowel disease‐associated arthritis (IBD‐AA); or (3) magnetic resonance imaging‐confirmed inflammatory sacroiliitis in patients who did not meet JIA subtype criteria. All children underwent complete HLA‐B testing. Comparisons of HLA‐B allele frequencies between JSpA and a published national cohort were conducted through two‐sample tests of proportions and controlled for multiple testing using the Benjamini–Hochberg procedure. Results: There were 150 children who met the inclusion criteria, and 28% (42 of 150) were HLA‐B*27 ‐positive. Overall, participants exhibited pronounced heterogeneity in phenotypic and allelic composition, with HLA‐B variants associated with distinct patterns of disease expression. Overall, HLA‐B*35:02 was significantly enriched in children with IBD‐AA ( P = 0.007) and in the overall occurrence of IBD ( P = 0.005), whereas HLA‐B*57:01 was significantly enriched in children with PsA ( P = 0.006). Conclusion: These patterns suggest a key role for HLA‐B variants in disease pathogenesis, possibly driving diverse JSpA expression through distinct immunogenetic dysregulation. Our findings underscore the need to further elucidate the biologic connection between HLA‐B and JSpA, with potential insights that may inform clinical care and guide future investigation.

  • Open Access

    Measuring the Impact: Magnetic Resonance Imaging Response of Sacroiliac Joints to Tumor Necrosis Factor Inhibitors in Youth With Axial Disease

    by Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss

    Objective: To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes (PROs) in youth with axial juvenile spondyloarthritis (axJSpA) initiating tumor necrosis factor inhibitor (TNFi). Methods: This prospective, multicenter study included youth aged 8 to 18 years with a clinical diagnosis of axJSpA starting TNFi. Assessments were conducted at baseline and 12 weeks, including clinical evaluation, magnetic resonance imaging (MRI), and PROs. Participants with persistent SIJ inflammation at 12 weeks were reassessed at 24 weeks. Three blinded reviewers evaluated MRIs using Spondyloarthritis Research Consortium of Canada SIJ inflammation scores (SIS) and SIJ structural scores. Results: Of 75 enrolled participants, 73 completed baseline visits, and 62 had MRI‐confirmed axJSpA. Fifty‐seven completed a 12‐week follow‐up; 89% (51 of 57) showed SIS improvement, and 63% (36 of 57) achieved inflammation resolution (SIS <2). Median SIS change from baseline to 12 weeks was −8 (interquartile range: −18 to −3). Among those with persistent inflammation at 12 weeks (n = 26), 85% reported at least moderate clinical improvement. At 24 weeks, 56% (14 of 25) had ongoing inflammation. A total of 84% of SIS improvement occurred within the first 12 weeks. In patients with at least two scans, structural lesion scores decreased, increased, or stayed the same from baseline to the 12‐week scan for erosions (58%/25%/18%), sclerosis (21%/9%/70%), fat metaplasia (0%/30%/70%), and backfill (4%/28%/68%). Conclusion: Most participants showed early imaging response to TNFi, with most improvement occurring within 12 weeks. Despite residual inflammation persisting in nearly half of patients, most reported symptom improvement, underscoring both the rapid impact of TNFi and the heterogeneity of treatment effects. image

  • Open Access

    Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis

    by Adam S Mayer, Rui Xiao, Timothy G Brandon, Pamela F Weiss, Juvenile Axial Spondyloarthritis Research Taskforce (JAxSpRT)

    Objectives: The impact of biologic sex in axial juvenile spondyloarthritis (axJSpA) is unknown. We assessed whether biologic sex is associated with disease manifestations, patient-reported outcomes, or characteristic sacroiliac joint (SIJ) MRI lesions in a large cohort of youths with classified axJSpA. Methods: This international multicentre cross-sectional study included youths aged <18 years with physician-diagnosed juvenile spondyloarthritis and fulfilling the classification criteria for axJSpA. Clinical and SIJ MRI data were available from the time axial disease was first diagnosed and were compared between males and females using Pearson’s chi-squared and Wilcoxon rank-sum tests, as appropriate. Multivariable logistic regression evaluated the association of sex with inflammatory and structural MRI lesions typical of axial disease. Results: Among the 143 patients included, 67.1% were male. Males had significantly greater HLA-B27 positivity, hip/groin stiffness and inflammatory marker elevation. There were no differences in peripheral arthritis, enthesitis or patient-reported outcomes. On SIJ MRI, males had significantly higher odds of unequivocal inflammatory lesions (OR 4.86, 95% CI 1.37–17.32), bone marrow oedema (OR 4.13, 95% CI 1.17–14.62) and pelvic enthesitis (OR 5.23, 95% CI 1.39–19.61) compared with females, but no differences in structural lesions were found. Conclusion: In a large multicentre axJSpA cohort, males were significantly more likely to have clinical and MRI features of inflammatory sacroiliitis at the time axial disease was first diagnosed. Future trials in axJSpA should strongly consider stratification by sex in their design.


  • Open Access

    Diffusion‐Weighted Imaging for the Evaluation of the Sacroiliac Joint in Pediatric Patients

    by Michael L. Francavilla, Timothy G. Brandon, Dmitry Khrichenko, Rui Xiao, Nancy A. Chauvin, Asef Khwaja, Pamela F. Weiss

    Objective: Maturational signal in the sacroiliac joint (SIJ) of skeletally immature youth is often misinterpreted as inflammation. Diagnostic tools that improve specificity are greatly needed. Apparent diffusion coefficient (ADC) values from diffusion‐weighted imaging (DWI), when used with standard imaging, may enhance diagnostic accuracy. We aimed to define normative pediatric ADC values and establish thresholds to distinguish normal from inflammatory SIJ signals. Methods: ADC values were measured using circular regions of interest (ROIs) on the anterior, central, and posterior slices of the cartilaginous SIJs (36 total ROIs). Mean ADCs were analyzed by age group, bone (iliac or sacral), and joint height (superior, mid, inferior), accounting for within‐patient clustering. In sacroiliitis cases, ROIs were placed on DWI at sites of increased signal on fluid‐sensitive sequences. Thresholds differentiating normal and inflammatory signals were derived by age, bone, and joint height (ilium only) and assessed by area under the receiver operating characteristic (AUROC) and specificity. Results: The reference group included 86 youth. Inferior ilium ADC values were higher than mid and superior regions in all immature age groups (all P < 0.0001) and decreased with age ( P = 0.0001). Sacral ADCs also declined with age ( P = 0.0001). No age trend was observed in the superior or mid ilium ( P = 0.14). ADC thresholds distinguished normal from inflammatory signals with AUROC ≥0.90 in most iliac regions, except the peripubertal inferior ilium (AUROC 0.78). Sacral thresholds performed acceptably (AUROC ≥ 0.77), though they were lower in the prepubertal group (AUROC 0.68). Conclusion: Age‐ and bone‐specific ADC reference values were established and effectively differentiated normal from inflammatory SIJ signals. image


  • Open Access

    Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis

    by Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss

    Objective: The objective of this study was to determine a core set of measures for youth with juvenile spondyloarthritis and axial disease (axJSpA), using the juvenile arthritis working group Outcome Measures in Rheumatology framework.Methods: This was a prospective multicenter study of youth with axJSpA. Participants (aged 8–18 years) all initiated tumor necrosis factor inhibitor (TNFi) therapy and completed questionnaires, examinations, and magnetic resonance imaging (MRI) at baseline and 12 weeks. Responsiveness and discrimination were assessed using standardized response mean (SRM) and standardized mean difference (SMD). For highly correlated (r > |0.80|) items within domains, larger SRM and SMD were prioritized, and minimal clinically important improvement was determined for each.Results: Of the evaluable cohort (N = 57), 68.4% were male, and the median age was 15.3 years; 70.2% of youth treated with TNFi had clinical response (change ≥2 in patient global assessment). Although 58% had continued MRI inflammation, 77% of those patients reported moderate clinical improvement. The final axJSpA core set contained the following: Patient‐Reported Outcomes Measurement Information System (PROMIS) pain interference (SRM 0.77, SMD 0.5), the sacroiliac joint inflammation score (SRM 1.02, SMD 0.52), PROMIS mobility (SRM 0.83, SMD 0.75), and patient global well‐being (SRM 0.88, SMD not applicable). All overall and composite disease activity measures tested, except the physician global assessment, had high SRM and SMD. Subgroup analysis demonstrated differences by biologic sex and overweight status. Improvement in the MRI inflammation score was greater in male patients. Improvement in the PROMIS pain interference and mobility measures was greater in those with normal body mass index.Conclusion: A set of measures was developed for youth with axJSpA. image


  • Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis‐Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?

    by Pamela F. Weiss, Timothy G. Brandon, Amita Aggarwal, Ruben Burgos‐Vargas, Robert A. Colbert, Gerd Horneff, Ronald M. Laxer, Kirsten Minden, Angelo Ravelli, Nicolino Ruperto, et al.

    Objective: The Paediatric Rheumatology International Trials Organisation (PRINTO) recently undertook an effort to better harmonize the pediatric and adult arthritis criteria. These provisional criteria are being refined for optimal performance. We aimed to investigate differences between patients who did and did not fulfill these PRINTO criteria among youth diagnosed with juvenile spondyloarthritis (SpA) that met axial juvenile SpA (axJSpA) classification criteria.Methods: This was a retrospective cross‐sectional sample of youth diagnosed with juvenile SpA who met the axJSpA classification criteria. Demographics, clinical manifestations, and physician and patient‐reported outcomes were abstracted from medical records. Magnetic resonance imaging (MRI) scans underwent central imaging review by at least two central raters. Differences between groups were compared using Wilcoxon signed‐rank test or chi‐square test, as appropriate.Results: Of 158 patients who met axJSpA criteria, 107 patients (68%) met the PRINTO provisional criteria for enthesitis/spondylitis‐related arthritis. A total of 41 patients (26%) did not fulfill any of the three major PRINTO criteria due to lack of peripheral disease manifestations. Demographics, prevalence of inflammatory or structural lesions on MRI, family history of SpA, and duration of pain were not statistically different between those who did and did not meet PRINTO criteria. Those who fulfilled the PRINTO criteria had significantly more peripheral arthritis, enthesitis, and HLA‐B27 positivity but reported less sacral/buttock pain.Conclusion: Phenotypic differences of children with axJSpA between those who were and were not classified by the PRINTO criteria were primarily due to peripheral disease manifestations and HLA‐B27 positivity. Modification of the PRINTO provisional criteria may facilitate capture of youth with primarily axial disease.


  • Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis

    by Adam Mayer, Timothy G. Brandon, Amita Aggarwal, Ruben Burgos-Vargas, Robert A. Colbert, Gerd Horneff, Rik Joos, Ronald M. Laxer, Kirsten Minden, Angelo Ravelli, et al.

    Objective: To evaluate the influence of pelvic magnetic resonance imaging (MRI) findings on axial disease assessment in juvenile spondyloarthritis (JSpA).Methods: This was a cross-sectional study of patients with JSpA with suspected axial disease. Three experts reviewed each case and rated their confidence (–3 to +3) in the presence of axial disease, first with clinical data and second with clinical and MRI data. Agreement was defined as ≥ 2/3 clinical experts with a rating of ≤ –1 or ≥ 1, and high confidence agreement as ≤ –2 or ≥ 2. The association of clinical features and both global assessments was tested with modified Poisson regression models.Results: Two hundred seventy-two of 303 cases (89.8%) achieved agreement with clinical data alone. Adding imaging data affected agreement in 38.9% (118/303) and directionality of agreement in 23.4% (71/303). Agreement was facilitated in 26/31 cases and lost in 21/272 cases. Of those 71 cases that changed directionality, 33 changed from axial disease being absent to present and 38 from present to absent. The final model had an area under the receiver-operating characteristic (AUROC) curve of 0.93 and 3 factors were independently associated with expert agreement (HLA-B27: relative risk [RR] 1.41, 95% CI 1.14-1.74; pain improvement with activity: RR 1.27, 95% CI 1.05-1.54; and bone marrow edema on MRI: RR 4.08, 95% CI 2.91-5.73).Conclusion: The addition of imaging data affected directionality and improved high confidence agreement of expert assessment of axial disease. These results underscore the integral role of MRI in the determination of axial disease in JSpA.


  • Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis

    by Pamela F. Weiss, Timothy G. Brandon, Amita Aggarwal, Ruben Burgos‐Vargas, Robert A. Colbert, Gerd Horneff, Ronald M. Laxer, Kirsten Minden, Angelo Ravelli, Nicolino Ruperto, et al.

    Objective: The goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA).Methods: This international initiative consisted of four phases: (1) item generation, (2) item reduction, (3) criteria development, and (4) validation of the AxJSpA criteria by an independent team of experts in an internationally representative validation cohort.Results: These criteria are intended to be used on youth with a physician diagnosis of juvenile SpA and for whom axial disease is suspected. Item generation consisted of a systematic literature review and a free‐listing exercise using input from international physicians, which collectively resulted in 108 items. After the item reduction exercise and expert panel input, 37 items remained for further consideration. The final AxJSpA criteria domains included the following: imaging of active inflammation, imaging of structural lesions, pain chronicity, pain pattern, pain location, stiffness, and genetics. The most heavily weighted domains were active inflammation and structural lesions on imaging. Imaging typical of sacroiliitis was deemed necessary, but not sufficient, to classify a youth with AxJSpA. The threshold for classification of AxJSpA was a score of ≥55 (out of 100). When tested in the validation data set, the final criteria had a specificity of 97.5% (95% confidence interval [CI] 91.4%–99.7%), sensitivity of 64.3% (95% CI 54.9%–73.1%), and area under the receiver operating characteristic curve of 0.81 (95% CI 0.76%–0.86%).Conclusion: The new AxJSpA classification criteria require an entry criterion and a physician diagnosis of juvenile SpA and include seven weighted domains. The AxJSpA classification criteria are validated and designed to identify participants for research studies. image


  • Open Access

    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study

    by Katelyn H. Baggett, Timothy G. Brandon, Rui Xiao, Pamela F. Weiss

    Objective: Given the multifactorial pathogenesis of juvenile spondyloarthritis (JSpA) and evidence of a protective effect in phenotypically similar diseases, we aimed to test whether breastfeeding is associated with the development and disease activity of JSpA.Methods: This single-center retrospective case-control study included children with JSpA and age- and sex-matched controls with a 1:1 ratio. Univariable and multivariable conditional logistic regression modeling for matched pairs was used to test the association of infant factors with the development of JSpA, including infant nutrition and form of delivery. Linear regression was used to assess the association of JSpA disease activity (JSpA Disease Activity Index with 6 elements [JSpADA6]) at presentation with breastfeeding exposure, form of delivery, and antibiotic exposure.Results: For the 195 case-control matched pairs, the mean age was 13.0 years and 47.7% were female. For breastfeeding, 88.7% of controls and 69.2% of JSpA cases were exposed to breastfeeding of any duration, respectively (P< 0.001). In the multivariable model, exclusive breastfeeding > 6 months was independently and significantly associated with a lower chance of JSpA development (odds ratio 0.47, 95% CI 0.30-0.72;P< 0.001). The median JSpADA6 was not significantly associated with breastfeeding for > 6 months. However, vaginal delivery was significantly associated with a lower JSpADA6 (B = −0.65, 95% CI −1.13 to −0.17;P= 0.008).Conclusion: This study suggests that infant factors that affect the microbiome may be associated with the occurrence and disease activity of JSpA at presentation.


  • Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis

    by Pamela F. Weiss, Timothy G. Brandon, Robert G. Lambert, David M. Biko, Nancy A. Chauvin, Michael L. Francavilla, Nele Herregods, Alison M. Hendry, Walter P. Maksymowych

    Objective: Radiography is still used worldwide for the detection of sacroiliitis in juvenile spondyloarthritis (JSpA), despite its low sensitivity and reliability. We aimed to define unequivocal evidence of sacroiliitis on pelvic radiography in skeletally immature youth for use in classification criteria when magnetic resonance imaging (MRI) is unavailable.Methods: Subjects were a retrospective cohort of juvenile patients with spondyloarthritis with a radiograph and MRI as part of a diagnostic evaluation for axial disease. Six musculoskeletal imaging experts underwent an iterative consensus process to define unequivocal sacroiliitis on radiography in skeletally immature youth. Radiographs were graded using the modified New York (mNY) criteria and the unequivocal sacroiliitis criteria. Interrater agreement was assessed with the Fleiss statistic. Specificity, area under the receiver operator characteristic curve (AUROC), and sensitivity of the 2 measures were tested using 2 MRI reference standards.Results: A total of 112 subjects, with a median age of 14.9 (range 6.7-20.1) years, were included. The Fleiss was fair for the mNY criteria (0.54, 95% CI 0.42-0.67) and the unequivocal sacroiliitis criteria (0.58, 95% CI 0.46-0.69). The unequivocal sacroiliitis criteria achieved > 90% specificity using both MRI reference standards. Sensitivity (59.26 and 57.14 vs 44.83 and 43.33) and AUROC (0.76 and 0.76 vs 0.71 and 0.71) were higher, for both reference standards, for the unequivocal sacroiliitis in youth definition than for the mNY criteria, respectively.Conclusion: In this study, we propose the first consensus-derived definition to our knowledge of unequivocal sacroiliitis by radiography in skeletally immature youth. This definition achieved excellent specificity and had higher AUROC and sensitivity values than the mNY criteria using both MRI reference standards. This definition has applicability to the JSpA axial disease classification imaging criterion when MRI is unavailable.